Insider Transactions in Q3 2021 at Zymeworks Inc. (ZYME)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 31
2021
|
Anthony J. Polverino Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,900
+11.88%
|
$73,500
$15.0 P/Share
|
|
Jul 16
2021
|
Ali Tehrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
41,191
-13.66%
|
$1,482,876
$36.0 P/Share
|
|
Jul 16
2021
|
Ali Tehrani Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,191
+12.02%
|
$164,764
$4.26 P/Share
|
|
Jul 15
2021
|
Ali Tehrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,800
-1.44%
|
$136,800
$36.0 P/Share
|
|
Jul 15
2021
|
Ali Tehrani Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+1.42%
|
$15,200
$4.27 P/Share
|
|
Jul 12
2021
|
Ali Tehrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,669
-4.64%
|
$456,084
$36.12 P/Share
|
|
Jul 12
2021
|
Ali Tehrani Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,669
+4.43%
|
$50,676
$4.31 P/Share
|
|
Jul 06
2021
|
Neil Josephson Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
461
+18.33%
|
$13,369
$29.49 P/Share
|
|
Jul 06
2021
|
James Priour Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
510
+16.87%
|
$14,790
$29.49 P/Share
|
|
Jul 06
2021
|
Neil A Klompas Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
299
+2.7%
|
$8,671
$29.49 P/Share
|
|
Jul 06
2021
|
Anthony J. Polverino Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
454
+1.42%
|
$13,166
$29.49 P/Share
|
|
Jul 06
2021
|
Kathryn O'Driscoll Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
510
+7.43%
|
$14,790
$29.49 P/Share
|